Charles Robb
2018
In 2018, Charles Robb earned a total compensation of $2.8M as Chief Financial Officer and Secretary at Corcept Therapeutics, a 60% increase compared to previous year.
Compensation breakdown
Bonus | $237,600 |
---|---|
Option Awards | $2,171,400 |
Salary | $436,667 |
Total | $2,845,667 |
Robb received $2.2M in option awards, accounting for 76% of the total pay in 2018.
Robb also received $237.6K in bonus and $436.7K in salary.
Rankings
In 2018, Charles Robb's compensation ranked 4,091st out of 14,244 executives tracked by ExecPay. In other words, Robb earned more than 71.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,091 | 71st |
Manufacturing | 1,507 | 74th |
Chemicals And Allied Products | 537 | 75th |
Drugs | 449 | 75th |
Pharmaceutical Preparations | 346 | 75th |
Robb's colleagues
We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2018.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019